Management Consulting

Portfolio Management

Financial solutions tailored to your business goals

Benefit from customized solutions aimed at optimizing returns and managing risks through asset prioritization and diversification in adjacent markets with Alira Health Portfolio Management.

A proprietary methodology backed by experience

Many of our clients structure their company around a specific platform to develop many assets in very different markets. And while spreading risk over several assets is always positive, as companies face resource shortages, they need to focus on a limited number of opportunities with increased probabilities of success to convince investors.

To meet those needs, Alira Health has developed a proprietary methodology and associated tools to allow our clients to prioritize assets and define an investment strategy that ensures operational success and value creation.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • An integrated team with experience across the product lifecycle
  • Proprietary digital tools tailored to your business needs
  • Click here to see our approach in action for a leading pharmaceutical company

Related news

Pharma
Events October 13, 2021
Event: World Drug Safety Congress
Join our team of experts at World Drug Safety Congress in Boston, MA.
Pharma
Events October 1, 2021
Event: Meeting on the Mesa
Join us at Meeting on the Mesa in Carlsbad, CA on October 11-14, 2021.
Pharma Research & Development
Publications August 2, 2021
Infographic: Prioritization Strategy of R&D Targets for Biotech Company
Download our infographic on Prioritization Strategy of R&D Targets for Biotech Company
Due Diligence Pharma
News July 21, 2021
Alira Health Announces its Role as Strategic Advisor to Naxicap
Alira Health is proud to announce its role as strategic advisor to Naxicap in the equity investment in Ceres Pharma Bv.
Due Diligence MedTech Patient Engagement Pharma
Multimedia April 12, 2021
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)
M&A MedTech Pharma
News April 12, 2021
Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.